Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 16

Risk Factors and Prediction Nomogram of Cognitive Frailty with Diabetes in the Elderly [Letter]

Authors Suyanto E, Fajar I, Hariyanto T

Received 15 November 2023

Accepted for publication 27 November 2023

Published 1 December 2023 Volume 2023:16 Pages 3899—3900

DOI https://doi.org/10.2147/DMSO.S450060

Checked for plagiarism Yes

Editor who approved publication: Prof. Dr. Muthuswamy Balasubramanyam



Edy Suyanto,1 Ibnu Fajar,2 Tanto Hariyanto3

1Nursing Department, Poltekkes Kemenkes Malang, Malang, Indonesia; 2Nutrition Department, Poltekkes Kemenkes Malang, Malang, Indonesia; 3Blood Bank Technology Department, Poltekkes Kemenkes Malang, Malang, Indonesia

Correspondence: Edy Suyanto, Poltekkes Kemenkes Malang, Jl. Ijen 77C, Malang, Indonesia, Email [email protected]


View the original paper by Miss Deng and colleagues


Dear editor

The article with the title “Risk Factors and Prediction Nomogram of Cognitive Frailty with Diabetes in the Elderly” caught our attention because it produces a nomogram prediction model that can be used to predict cognitive frailty in elderly diabetic patients. This nomogram involves six factors (age, albumin levels, calf circumference, intellectual activity, depressive state, and duration of diabetes), which were obtained from the results of analysis. In the initial stage of analysis there were 12 significant risk factors for cognitive frailty, but in the final stage there were only 6 significant factors, namely age, albumin levels, calf circumference, intellectual activity, depressive state, and duration of diabetes. Meanwhile, factors that are not significant include walking assistance, self-care ability, BMI, hemoglobin, creatinine, and grip strength.1 Is it true that these last six factors have no effect on cognitive frailty? Could these factors have an indirect effect?

Researchers used a logistic regression test to analyze the significance of cognitive frailty risk factors, so that indirect effects could not be detected, because this test assumes that all factors have a direct effect. If we suspect that one of the factors, for example self-care ability, has an indirect effect, then we have to go through an intermediate variable, for example depressive state. So first self-care ability affects depressive states and then depressive states affect cognitive frailty.2

Therefore, we recommend that further analysis be carried out to prove the existence of indirect effects from the 12 factors. In this case, the method that can be used is path-analysis. Because researchers use nominal scale data, one program that can be used is Smart-PLS.3–5 We hope that the results of this advanced analysis will provide more accurate information for improving predictive models in the future.

Disclosure

The authors report no conflicts of interest in this communication.

References

1. Deng Y, Li N, Wang Y, Xiong C, Zou X. Risk factors and prediction nomogram of cognitive frailty with diabetes in the elderly. Diabetes Metab Syndr Obes. 2023;16:3175–3185. doi:10.2147/DMSO.S426315

2. Buis ML. Direct and indirect effects in a logit model. Stata J Winter. 2010;10(1):11–29.

3. Nugroho HSW, Acob JRU, Martiningsih W. Healthcare worker’s mental health during the epidemic peak of covid-19 [Letter]. Psychol Res Behav Manag. 2021;14:333–334. doi:10.2147/PRBM.S309309

4. Nugroho HSW, Suparji S, Martiningsih W, Suiraoka IP, Acob JRU, Sillehu S. A response to “effect of integrated pictorial handbook education and counseling on improving anemia status, knowledge, food intake, and iron tablet compliance among anemic pregnant women in Indonesia: a quasi-experimental study” [Letter]. J Multidiscip Healthc. 2020;13:141–142. doi:10.2147/JMDH.S247401

5. Susatia B, Martiningsih W, Nugroho HSW. A response to “prevalence and associated factors of musculoskeletal disorders among cleaners working at Mekelle University, Ethiopia”. J Pain Res. 2020;13:2707–2708. doi:10.2147/JPR.S281683

Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.